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BORIS/CTCFL is an RNA-binding protein that
associates with polysomes
Babatunji W Ogunkolade1†, Tania A Jones1†, Johan Aarum1†, Jaroslaw Szary1, Nicholas Owen1, Diego Ottaviani1,
Muhammad A Mumin1, Shyam Patel1, Christopher A Pieri1, Andrew R Silver2 and Denise Sheer1*
Abstract
Background: BORIS (CTCFL), a paralogue of the multifunctional and ubiquitously expressed transcription factor
CTCF, is best known for its role in transcriptional regulation. In the nucleus, BORIS is particularly enriched in the
nucleolus, a crucial compartment for ribosomal RNA and RNA metabolism. However, little is known about
cytoplasmic BORIS, which represents the major pool of BORIS protein.
Results: We show, firstly, that BORIS has a putative nuclear export signal in the C-terminal domain. Furthermore,
BORIS associates with mRNA in both neural stem cells and young neurons. The majority of the BORIS-associated
transcripts are different in the two cell types. Finally, by using polysome profiling we show that BORIS is associated
with actively translating ribosomes.
Conclusion: We have demonstrated the RNA binding properties of cellular BORIS and its association with actively
translating ribosomes. We suggest that BORIS is involved in gene expression at both the transcriptional and
post-transcriptional levels.
Keywords: CTCF, Ribosomes, Nucleoli, WNT signalling
Background
CTCF is a highly conserved and ubiquitous protein that
has widespread functions in transcription regulation and
chromatin architecture. It acts as a silencing and activat-
ing transcriptional factor, a chromatin insulator and a
mediator of chromatin looping, and is essential for life
[1,2]. Binding of CTCF to DNA is achieved primarily
through its 11-zinc finger domain, which also facilitates
protein-protein interactions [3-5]. CTCFL or BORIS
(Brother of the Regulator of Imprinted Sites), is a paralo-
gue of CTCF [1]. BORIS has almost identical 11 zinc
finger domains to CTCF, and the proteins are thought
to have evolved during vertebrate development from a
gene duplication event [6]. However, the flanking N- and
C-terminal regions of BORIS show no homology with
CTCF or any other proteins [7]. BORIS also lacks the
modular substrates for specific post-translational modifi-
cations that are critical for CTCF function, suggesting di-
vergent roles for the two proteins. Indeed, BORIS and
CTCF are expressed in a mutually exclusive manner dur-
ing male germ-line development, suggesting that BORIS is
involved in reprogramming the paternal DNA-methylation
patterns [8]. Several lines of evidence suggest that BORIS
plays a role in epigenetic regulation of gene expression. In
tumour cell lines, where CTCF silences genes by DNA
methylation, it has been shown that expression of BORIS
can displace CTCF at these genes leading to local demeth-
ylation and gene activation [9-12]. Further epigenetic regu-
lation is suggested by the binding of BORIS to the
upstream binding factor (UBF), a transactivator of RNA
polymerase I, which is involved in the maintenance of
chromatin structure [13].
BORIS protein is readily detected in most cells and tis-
sues [14], with abnormally high expression levels re-
ported in several tumours and cell lines [15-22]. In
contrast to previous findings suggesting divergence in
the roles of BORIS and CTCF, recent evidence has
shown that both proteins are able to mediate similar
growth and tumour suppressor functions and both
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provide a protective effect during apoptosis [23]. This
finding warrants further characterisation of the func-
tional properties of BORIS.
We previously showed that BORIS is present both in
the cytoplasm and nucleus, and is enriched in the nucle-
olus, a crucial compartment for ribosomal RNA and
RNA metabolism [14]. The role of BORIS within the
cytoplasm, which represents the major pool of BORIS
protein in testis, has not been fully explored [24]. Here,
we hypothesized that cytoplasmic BORIS interacts with
RNA, as shown for certain other Zn-finger proteins
[25,26], due to the subnuclear localisation of BORIS to
the nucleolus, which is associated with RNA metabol-
ism. To test this, we examined whether BORIS binds
RNA and if so, whether this property changes in cells as
they undergo phenotypic alterations. We show BORIS
binds to distinct sets of RNA transcripts in neural stem
cells and neurons and to a substantial amount of non-
coding RNA. The transcripts are enriched for compo-
nents of certain key cellular pathways including the
WNT pathway. We further find that BORIS is associated
with actively translating ribosomes. Together, our data
suggest new roles for BORIS in the regulation of gene
expression.
Results
BORIS is an RNA binding protein
Association of BORIS with newly synthesized RNA was
first suggested by a run-on transcription assay on
HEK293T cells, which showed that BORIS co-localises
with 5-FU in punctate foci in both the nucleus and cyto-
plasm (Additional file 1: Figure S1). Analysis of the
amino acid sequence of BORIS revealed the presence of
a putative nuclear export signal (NES) in the C terminal
region (Figure 1), indicating that the protein may shuttle
between the nucleus and cytoplasm.
We therefore extended our investigation to determine
whether BORIS interacts with RNA in other cell types
and, if so, whether the interaction changes as cells
undergo phenotypic alterations. We previously showed
that BORIS is present at similar levels in hNP1 neural
progenitor cells (Aruna Biomedical) and young neurons
derived from hNP1 using well-defined culture conditions
[14]. Gene expression arrays confirmed no significant
change in expression of BORIS during neural differenti-
ation (data available at NCBI’s Gene Expression Omnibus
[27], accession number GSE42294). Expression of BORIS
in hNP1 and HEK293T cells was confirmed by partial
sequencing of PCR product (Additional file 2: Figure S2).
To investigate if BORIS associates with endogenous
RNA in hNP1 cells and hNP1 cells differentiated to neu-
rons over 6 days (designated 6dN), we used oligo dT
beads to precipitate mRNA from cell lysates and ana-
lysed co-precipitated proteins by Western Blot. In both
cell types, BORIS was precipitated (Figure 2A), suggest-
ing that the protein associates with mRNA. Similar re-
sults were obtained by oligo-dT-precipitation of protein
complexes from HEK293T cells transiently expressing
GFP-tagged BORIS protein, as detected by both anti-
GFP antibodies and anti-BORIS antibodies (Figure 2B).
No GFP was precipitated from cell lysates expressing
GFP only (Figure 2B).
We then used native RNA-immunoprecipitation to
isolate RNAs that were associated with BORIS. A sub-
stantial amount of nucleic acids (5-15% of input) was
consistently immunoprecipitated from both hNP1 and
6dN cells. To verify that this was RNA and not contamin-
ating DNA, since BORIS is known to bind DNA [28,29],
we treated the immunoprecipitates with RNase A or
DNase I and quantified the remaining nucleic acid. Only
RNase A treatment decreased the amount of precipitated
nucleic acids, while DNase I had no effect (Figure 3A).
Gel electrophoresis analysis of BORIS-precipitated RNA
revealed a prominent band migrating as 28S rRNA, and a
weaker band as 18S, suggesting that BORIS associates
with ribosomes (Figure 3B and C). In comparison, no
detectable RNA was precipitated by non-specific IgGs
(Figure 3B and C).
Figure 1 Amino acid sequence of BORIS showing predicted nuclear localisation signal (green) and nuclear export signal (blue).
The unstructured N and C terminal regions [7] that flank the 11 Zinc-finger domains (black) are coloured red. In the C-terminal region, bold,
underlined residues (green) represent a predicted nuclear localisation signal (NLS) (http://www.sbc.su.se/~maccallr/nucpred/cgi-bin/single.cgi).
At the end of the C-terminal region, bold, underlined residues (blue) represent a predicted nuclear export signal (NES) (http://www.cbs.dtu.dk/
services/NetNES/). The predicted export signal was identified when using the unstructured C-terminal (red) as input. No other NES were found
in the other regions, i.e. the unstructured N-terminus or the Zinc-finger region.
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Next, to determine whether BORIS binds directly to
RNA, a series of 20 mer RNA and DNA homopolymers
with 3’ Biotin-TEG was utilised in an in vitro binding
assay. Recombinant BORIS was purified from HEK293T
cells (Figure 4A) and assayed for its ability to bind to the
biotin-coupled homopolymers. As expected, we found
that BORIS associates with the DNA homopolymers
poly(dT), poly(dG) and poly(dC) [30]. In addition, BORIS
also bound to poly(rG) and, to a lesser extent, to poly(rU)
RNAs, while no binding was observed to polymers of
rC or rA or to the streptavidin beads alone (Figure 4B).
These experiments suggest that BORIS can interact dir-
ectly with RNA.
Identification of poly(A) RNAs bound to BORIS
To identify which transcripts were associated with
BORIS in hNP1 and 6dN cells we immunoprecipitated
the protein from cellular extracts. We then isolated the
RNA and converted it to cDNA, which was hybridized
to gene expression arrays. The signals from the arrays
were then compared to those obtained from total RNA
isolated from hNP1 and 6dN cells. Transcripts were
scored as associated with BORIS if the fold change was
larger than two and the p-value (ANOVA) was less than
0.01 (see Methods). In total, we identified 1097 and 962
probes representing 863 and 771 unique transcripts as-
sociated with BORIS in hNP1 and 6dN cells, respectively
(Additional file 3: Table S1 and Additional file 4: Table S2).
Of these, 88 transcripts were common to both hNP1 cells
and 6dN cells (Figure 4C). These findings were confirmed
for several genes by the validation of enrichment using
RT-qPCR in hNP1 and 6dN cells (Figure 4D,E). In
addition, we showed that the association of transcripts
with BORIS did not correlate with their up- or down
regulation during neural differentiation (Additional file 5:
Table S3).
Characterisation of BORIS-bound transcripts
We first used the PANTHER Protein Class Ontology plat-
form [31] to identify over-represented pathways in each
cell type. In hNP1 cells, significant enrichment (p < 0.05)
was found for transcripts involved in WNT signalling,
cadherin signalling and Huntington disease (Figure 5A
and Table 1). In 6dN cells, significant enrichment
(p < 0.05) was found for transcripts involved in WNT sig-
nalling as well as angiogenesis, inflammation mediated by
chemokines and cytokine signalling, Alzheimer disease-
presenilin and TGF-β signalling (Figure 5B and Table 1).
PANTHER [31] was then used for functional analysis
of translated protein products for BORIS-associated
Figure 2 Western blot analysis of oligo-dT-precipitated RNA-protein complexes. (A) RNA-protein complexes form human neural progenitor
cells (hNP1) and hNP1 cells differentiated to neurons over 6 days (6dN) were precipitated with oligo-dT beads analysed by SDS page western blot
probed with anti-BORIS antibody (ab18337, Abcam). (B) Immuno-blotting of oligo-dT-RNA bound protein complexes from HEK293T cells transi-
ently expressing BORIS (C3-BORIS) or empty vector (C3-empty). Western blot analysis of Input (2%) and oligo-dT bound protein complex probed
with either anti- GFP or anti-BORIS.
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Figure 3 Characterisation of immunoprecipitated nucleic acids. (A) Quantification of BORIS and control IgG immunoprecipitated nucleic
acids before and after digestion with either DNase I or RNase A. (B and C) Agilent Bioanalyser gel-electrophoresis of BORIS and control IgG
precipitated RNA. The BORIS-precipitated samples revealed a prominent band migrating as 28S rRNA and a less prominent band as 18S in both
hNP1 (B) and hNP1 cells differentiated to neurons over 6 days (6dN) (C). Note the different scale of the Y-axis.
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transcripts. Significant enrichment (p < 0.05) was found in
DNA and RNA-binding proteins, as well as RNA splicing
factor activity in both hNP1 and 6dN cells (Figure 5C and D
and Table 1). PANTHER analysis also showed that BORIS-
associated transcripts are involved in diverse biological
processes (Figure 5E and F and Table 1). Over-represented
biological processes for transcripts from hNP1 include
metabolic process, cellular component organization, protein
transport, organelle organization, and nervous system
development. Over-represented biological processes for
Figure 4 BORIS binds directly to RNA in a nucleotide-specific manner. (A) SDS-PAGE western blot analysis of the purification of Halo tagged
BORIS from transfected HEK293T cells. (B) In vitro binding assay using biotinylated RNA and DNA homopolymers and purified recombinant BORIS
from (A). BORIS showed association with poly(rG) and poly(rU), but not with poly(rA) or poly(rC). BORIS also showed specific affinity for poly(dT),
poly(dG) and poly(dC) DNA while no binding was observed to poly(dA) or the streptavidin beads alone (No oligo, lane 1). (C) Venn diagram
showing the number of identified BORIS associated transcripts in hNP1 and hNP1 cells differentiated to neurons over 6 days (6dN) as well as the
number of transcripts associated with BORIS in both cell types. RT-qPCR confirmation of BORIS associated transcripts in hNP1 (D) and 6dN cells
(E). Data in (D) and (E) represent 2 technical replicates ± SD.
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transcripts from 6dN include cell cycle, primary metabolic
process, cellular process, transport (protein, ion etc.) and
mitosis.
BORIS expression activates the β-catenin dependent WNT
canonical pathway
In both hNP1 and 6dN cells, BORIS associates with sev-
eral transcripts of the WNT pathway, including APC,
TCF, lpd5/6, WNT5A and FZD5/10 (frizzled family re-
ceptor 5/10) (Additional file 6: Figure S4). To investigate
if BORIS can influence this key pathway, we over-
expressed BORIS in HEK293T cells and assessed the
protein levels of a set of WNT pathway components.
Over-expression of BORIS caused a significant increase
in the amount of TCF3 (p < 0.05) and WNT5A/B (p < 0.01)
protein (Figure 6A and Additional file 7: Figure S5). Whilst
we observed a slight increase in nuclear β-catenin, this was
not statistically significant and there was no overall in-
crease in total cellular β-catenin protein following BORIS
over-expression (Figure 6E). No change in protein levels
was found for LEF1 and TCF4 WNT pathway components.
Analysis of mRNA levels after BORIS over-expression
showed no alteration for most WNT pathway components,
while there was a significant decrease in expression for
TCF3 (p < 0.02), APC (p < 0.007) and WNT5A (p < 0.03)
(Figure 6B).
To determine directly if BORIS influences the activa-
tion of the WNT pathway, we then used a luciferase
reporter assay where the luciferase expression is driven
by tandem repeats of multiple copies of the consensus
TCF/LEF- β-catenin responsive element (SABiosciences).
LiCl, an inhibitor of GSK-3, was used as a positive control
for pathway activation [32]. Transient over-expression of
BORIS in HEK293T cells led to a more than four-fold in-
crease in luciferase activity compared to cells transfected
with empty vector alone (Figure 6C). This activation was
dependent on β-catenin as siRNA knock-down of
β-catenin caused a significant reduction in the effect of
BORIS over-expression in the TCF/LEF luciferase assay
(Figure 6D, E and F).
BORIS associates with polysomes
The large amount of RNA including ribosomal RNA,
bound to BORIS, suggested that BORIS interacts with
the translational machinery. To investigate this directly,
we performed polysome profiling on cell extracts prepared
Figure 5 Panther analysis of transcripts bound to BORIS. Significantly enriched PANTHER annotations identified for BORIS-associated transcripts.
Binomial distribution is applied to obtain p-values and p-values < 0.05 were considered. (A,B) Pathway analysis (C,D) Molecular function analysis and
(E,F) Biological processes. Left panel hNP1 cells, right panel hNP1 cells differentiated to neurons over 6 days (6dN). Observed values indicate the actual
number of transcripts form our lists assigned to a particular pathway/molecular function/biological process. The expected values indicate the number
of genes expected from our lists for each PANTHER category, based on the human genome reference list.
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from hNP1 and 6dN cells and analysed the distribution of
BORIS in the resulting gradients by Western blotting.
Consistent with a ribosomal association, BORIS was
present throughout the gradient, co-sedimenting with all
ribosomal subunits (40S and 60S) as well as monosomes
(80S) and polysomes (Figure 7A). A similar sedimentation
profile was observed for the ribosomal protein L7 (RPL7).
The majority of BORIS was detected in the light fractions
at the top of the gradient, where it co-sediments with the
ribosomal proteins S6. The cytoplasmic but non-ribosome
associated protein, GAPDH, was only detected in the light
fractions.
Polysome profiling of HEK293T cells showed a similar
sedimentation profile of BORIS to that observed in
hNP1 and 6dN cells (Figure 7B). Inhibition of translation
in HEK293T cells using puromycin, which causes prema-
ture chain termination and polysomal dissociation [33]
shifted BORIS and RPL7 to the first, light fractions
(Figure 7B). Furthermore, both RNase A digestion and
dissociation of ribosomes into subunits by 30 mM EDTA
with the concomitant release of mRNA and the 5S
Table 1 p-values for PANTHER analysis of pathways,
molecular function and biological processes of transcripts
bound in (A) hNP1 and (B) hNP1 cells differentiated to
neurons over 6 days (6dN)
A.
BORIS bound
transcripts
in hNP1
p-value
Pathway
WNT signaling pathway 33 0.00000258
Cadherin signaling pathway 23 0.00000012
Huntington disease 13 0.0252
Molecular function
binding 401 6.54E-18
nucleic acid binding 253 1.49E-14
DNA binding 164 2.39E-10
transcription factor activity 143 3.48E-09
transcription regulator activity 143 3.48E-09
RNA binding 48 7.86E-07
RNA splicing factor activity,
transesterification mechanism
27 3.56E-05
helicase activity 19 5.85E-05
RNA helicase activity 13 1.73E-04
catalytic activity 263 9.25E-04
Biological process
nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
252 8.72E-15
metabolic process 422 3.19E-08
primary metabolic process 407 5.66E-08
cellular component organization 94 1.45E-05
protein transport 103 2.76E-05
intracellular protein transport 103 2.76E-05
organelle organization 29 1.74E-04
establishment or maintenance
of chromatin architecture
27 2.42E-04
nervous system development 78 3.60E-04
vesicle-mediated transport 72 5.89E-04
Table 1 p-values for PANTHER analysis of pathways,
molecular function and biological processes of transcripts
bound in (A) hNP1 and (B) hNP1 cells differentiated to
neurons over 6 days (6dN) (Continued)
B.
BORIS bound
transcripts
in 6dN
p-value
Pathway
WNT signaling pathway 19 0.0325
Angiogenesis 16 0.00275
Inflammation mediated by chemokine
and cytokine signaling pathway
15 0.115
Alzheimer disease-presenilin pathway 12 0.00257
TGF-beta signaling pathway 10 0.049
Molecular function
binding 315 1.05E-06
nucleic acid binding 191 1.76E-05
catalytic activity 245 1.26E-04
protein binding 156 1.39E-04
transferase activity, transferring
glycosyl groups
22 1.67E-04
ubiquitin-protein ligase activity 29 2.83E-04
DNA binding 122 3.80E-04
transferase activity 85 6.67E-04
ligase activity 38 2.03E-03
RNA splicing factor activity,
transesterification mechanism
20 3.28E-03
Biological process
cell cycle 114 7.90E-08
primary metabolic process 368 8.83E-08
metabolic process 376 4.35E-07
nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
196 1.26E-06
protein transport 94 3.18E-05
intracellular protein transport 94 3.18E-05
protein metabolic process 162 5.45E-05
cellular process 284 5.66E-05
transport 145 7.51E-05
mitosis 41 6.49E-04
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Figure 6 (See legend on next page.)
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ribosomal protein [34,35], also shifted the sedimentation
of BORIS and to a lesser extent RPL7 towards lighter
fractions (Figure 7B). Together, these findings suggest
that BORIS associates with actively translating ribo-
somes in these cells.
Discussion
Here, we provide evidence that BORIS, best known for
its role in DNA binding and transcriptional regulation,
also binds RNA in vitro and associates with subsets of
mRNAs and with translating ribosomes in neural stem
cells and young neurons. The ability to bind to both
DNA and RNA is not unique to BORIS, and is a feature
of certain other zinc finger containing proteins [36-41].
The zinc finger domains of BORIS, with which it associ-
ates with DNA, are almost identical to those in CTCF and
the proteins are reported to share DNA binding sites in
the genome [8,11,24]. A recent study has suggested that
the zinc fingers in BORIS are needed for both nuclear and
nucleolar localisation [42]. It remains to be established
whether the zinc finger motifs are important for the RNA-
binding properties of BORIS, as is the case for TFIIIA
[37], WT1 [43] and certain other proteins [44].
An interesting feature of BORIS is that its mRNA ex-
pression is extremely low in cultured or primary cells,
yet the protein levels are readily detectable. This is
consistent, however, with a report that RNA binding
proteins tend to exhibit high protein stability and trans-
lational efficiency, yet their transcripts have a short half-
life [45]. The authors of the report suggest that tight
regulation of the levels of RNA binding proteins is re-
quired since a significant change in their expression may
affect many targets altering global expression levels.
Although the majority of BORIS-associated transcripts
differ between hNP1 and 6dN cells, similarities are ob-
served in the pathways in which the transcripts are
involved in the two cell types. For example, BORIS-
associated transcripts in both cell types encode proteins
involved in the canonical WNT pathway. WNT
signalling is crucial in the regulation of a wide range of
cellular processes such as apoptosis, cell proliferation, and
differentiation, including that of neural stem cells [46-48].
A role for BORIS in regulating WNT signalling is sup-
ported by our finding that BORIS increases the activity of
a TCF/LEF reporter following transient over-expression in
HEK293T cells (Figure 6C). As the reporter activation is
dependent on β-catenin (Figure 6F), BORIS is unlikely to
affect the TCF/LEF reporter directly, but rather to have a
post-transcriptional role. BORIS associates with several
transcripts coding for regulatory components of the path-
way and it is therefore conceivable that its over-expression
may affect the translation of WNT pathway components.
Indeed, BORIS over-expression leads to increased TCF3
and WNT5A protein levels, whilst their respective tran-
script levels are decreased (Figure 6A and B) Although
there are several possible explanations for this increase in
protein levels, for example post-translational modifica-
tions leading to greater protein stability [49,50], the fact
that BORIS associates to these transcripts as well as to ac-
tively translating ribosomes (Figure 7A,B) argues for a
translational effect of BORIS on these proteins. However,
further studies are required to conclusively answer this
question.
The biological consequences of the association of
BORIS with different transcripts within individual path-
ways in hNP1 and 6dN cells have yet to be determined.
BORIS may be involved in coordinated regulation of dif-
ferent transcripts within certain pathways at specific
time points of cell development or differentiation.
Conclusion
We show that BORIS can directly interact with RNA
in vitro and is associated with a subset of mRNA and
translating ribosomes in neural stem cells and young
neurons. Transient over-expression of BORIS increases
the protein levels of several BORIS-associated transcripts
without any concomitant increase in transcript levels sug-
gesting a role for BORIS in translational control.
(See figure on previous page.)
Figure 6 Activation of the WNT pathway after BORIS over-expression. (A) Western blot analysis of WNT5A/B and TCF3 in untransfected
control, mock transfected (C3-empty) or BORIS transfected (C3-BORIS) HEK293T cells. The upper band in the WNT5A/B blot is non-specific (*) as shown
by provider (Cell Signalling). The membranes were probed with the antibodies as indicated and GAPDH was used as a loading control. Lysates from
three independent experiments were loaded on the same gel. (B) mRNA levels of BORIS bound transcripts in HEK293T cells over-expressing BORIS
(C3-BORIS) as compared to empty vector (C3-empty). Data in (B) represent 2 technical replicates ± SD. (C) Luciferase activity of a TCF/LEF-responsive
element reporter after BORIS (C3-BORIS) or mock transfection of HEK293T cells. Over-expression of BORIS (C3-BORIS) led to a more than four-fold
increase in luciferase activity compared to cells transfected with empty vector alone (C3-empty). Cignal negative is a non-inducible reporter, lacking
the TCF/LEF response element. LiCl was used as a general activator of the TCF/LEF reporter. Data are expressed as a mean ratio of the Firefly/Renilla
luciferase activity (see Materials and Methods) and represents the average ± SD of 4 biological replicates. (D) Western blot analysis of HEK293T cells
after over-expression of BORIS together with siRNA knock down of β-catenin. LiCl treated cells (C3-empty + LiCl) were included in the analysis to
exclude a direct effect of LiCl on the expression of β-catenin. GAPDH was used as a loading control. (E) Densitometry quantification of β-catenin
expression in (D). Data represents the mean ± SD of 3 biological replicates. (F) Normalised TCF/LEF luciferase reporter activity after β-catenin knock-
down and BORIS over-expression in HEK293T cells. β-catenin knock-down efficiently prevented BORIS-mediated activation of the TCF/LEF luciferase
reporter, compared to Scrambled + Reporter with β-catenin siRNA + Reporter. Data shown is from one representative experiment.
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Methods
Cell culture
Human neural stem cells, hNP1, derived from the cell line
WA09 (46,XX) (Aruna Biomedical, hNP7013.1), were cul-
tured in Neurobasal medium (Invitrogen, 21103–049)
supplemented with B27 (Invitrogen, 12587–010), FGF-2
10 ng/ml, 1% penicillin/streptomycin and 2 mM glutam-
ine as previously reported [14]. Half the medium was
changed every other day. We induced differentiation by
omitting FGF-2 from the medium as described by Shin
Figure 7 Polysome profiling of BORIS. (A) Polysome profiles of cell lysates from hNP1 and hNP1 cells differentiated to neurons over 6 days
(6dN) on a 10-50% sucrose gradient. Lighter particles at the top of the gradient are shown on the left and heavier fractions are shown on the
right. Equal volumes of each fraction were analysed by SDS-PAGE and probed with indicated antibodies. S6 and RPL7 are ribosome-associated
proteins while GAPDH is not. (B) Polysome profiling of HEK293T cell lysates, detecting endogenous BORIS, after disruption of polysomes by
puromycin (top panel), 30 mM EDTA (middle panel) or following RNAse A digestion (lower panel).
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et al., [51]. Human embryonic kidney cells, HEK293T,
were maintained in RPMI containing 10% fetal bovine
serum 1% penicillin/streptomycin (Invitrogen) and 2 mM
glutamine at 37°C in 5% CO2 (Invitrogen).
Antibodies
BORIS antibody ab18337 (1:1000 dilution, Abcam),
CTCF antibody 07–729 (1:1000 dilution, Millipore) and
GAPDH antibody 14C10 (1:1000 dilution, Cell Signaling)
were used in Western data shown. The specificity of the
BORIS antibody was determined using recognition of
GFP-tagged recombinant BORIS and non-recognition of
GFP-tagged recombinant CTCF protein by western blot-
ting (Additional file 8: Figure S3). The specificity of the
BORIS antibody has also previously been confirmed by
siRNA knock down, peptide competition and the recog-
nition of recombinant BORIS [14]. WNT3a (C64F2)
rabbit monoclonal antibody, WNT5a/b (C27E8) rabbit
monoclonal antibody and LRP6 (C5C7) rabbit monoclo-
nal antibody were from the WNT signaling antibody
sampler kit, 2915 (Cell Signaling) and TCF3 (D15G11)
rabbit monoclonal antibody and TCF4 (C48H11) rabbit
monoclonal antibody were from the TCF/LEF1 antibody
sampler kit, 9383 (Cell Signaling) and were used at
1:1000 dilution.
Run-on transcription assay
For immunodetection of newly synthesized RNA, HEK293T
cells grown on coverslips were briefly incubated (15–
20 minutes at 37°C) with 2 mM 5'-fluorouridine (5-FU)
(F5130; Sigma) [52]. Cells were then fixed with 4%
paraformaldehyde for 10 min, permeabilised with 1%
Triton X-100, and incorporation of 5-FU into nascent
RNA was monitored using antibody against halogenated
UTP (1:100, anti-bromodeoxyuridine (BrdU) clone BU-33,
B8434; Sigma) and a Texas Red-conjugated secondary
antibody. Nuclei were stained with 0.1 mg/ml 4’, 6-
Diamidino-2-phenylindole (DAPI, Molecular Probes) and
mounted in Mowiol (Calbiochem). For standard 2 dimen-
sional analysis, specimens were visualized using a Zeiss
Axiophot microscope equipped for epifluorescence using
Zeiss plan-neofluar 100x objective. Separate grey-scale images
were recorded with a cooled CCD-camera (Hamamatsu).
Image analysis was performed using SmartCapture X
software (Digital Scientific).
Identification of nuclear export signal
Identification of a putative nuclear export signal (NES)
in the C terminal region was performed using NetNES
(http://www.cbs.dtu.dk/services/NetNES/).
Oligo-dT precipitation of BORIS
Cells were trypsinised, washed in ice cold buffer A
(10 mM Tris–HCl pH 7.5, 1.5 mM MgCl2, 0.2 mM
EDTA, 10 mM KCl) and lysed in buffer C (10 mM Tris–
HCl (pH 7.5), 100 mM NaCl, 2.5 mM MgCl2, 0.5%
Triton X-100, and 2unit/μl RNaseOUT). 1000 μg of pro-
tein lysate was incubated with 100 μl oligo-dT-dynabeads
(Invitrogen) and incubated at 4°C for 30 minutes. Oligo-
dT/mMRNA/protein complex was separated from un-
bound proteins using an Invitrogen magnetic separator.
The beads were washed five times with solution D
(20 mM Tris–HCl pH 8.0, 150 mM NaCl, 0.02% NP-40
and 1U/ml RNaseOUT) using at least twice the lysate vol-
ume for washing. Beads and attached complexes were re-
suspended in 20–40 μl PAGE loading buffer for western
blot analysis.
Identification of BORIS bound mRNAs
Immunoprecipitation of BORIS-mRNA complexes was
used to assess the association of BORIS with target
mRNAs as previously described with some modifica-
tion [53]. Briefly, 10–20 million cells were washed
with PBS and lysed in ice cold swelling buffer A
(25 mM HEPES, 1.5 mM MgCl2, 85 mM KCl, pH 8.0)
for 5 minutes. After spinning for 5 minutes at 4°C, the
pellet was lysed in buffer C (buffer A supplemented
with 0.2% NP-40, 1% Triton X-100, with 0.01% saponin,
1 × protease inhibitor cocktail (Roche), 2 U/ml of RNase-
OUT and phosphatase inhibitors mix (5 mM each of
Sodium Fluoride, Sodium Orthovanadate and beta-
glycerophosphate)) for 30 minutes and cleared by
centrifugation at 21,000 g for 10 minutes. The cleared
supernatant was incubated with 10 μg BORIS antibody
(ab18337, Abcam) coupled to dynabead protein A (100 μl)
(Invitrogen) for 1–2 hours at 4°C. After extensive washes
with buffer D (buffer A, supplemented with phosphatase
inhibitors mix, 1 × protease inhibitor cocktail (Roche),
0.1 U/ml of RNaseOut, 0.02% NP-40 and 0.25% Triton
X-100), the bead-protein complex was incubated with
50 units of DNase 1 containing 100 units of RNase-
OUT for 5 minutes at 37°C. An equal volume of pro-
teinase K containing buffer was added and incubated
for another 15 minutes at 37°C. RNA was extracted
with standard phenol chloroform procedure and precip-
itated with 2 μl of glycogen (Sigma-Aldrich).
The RNA was used for either hybridization to Affyme-
trix U133 plus 2.0 expression arrays or for RT-qPCR
verification of BORIS target transcripts. For array ana-
lysis, double stranded cDNA was synthesized from 1.5 –
5 μg total RNA using the Affymetrix One-cycle cDNA
synthesis kit following the manufacturer’s instructions
(Affymetrix). Synthesis of Biotin-labeled cRNA was per-
formed using the Affymetrix GeneChip IVT labeling kit
followed by purification with the sample cleanup mod-
ule. Labeled cRNA was then fragmented and hybridized
to Affymetrix GeneChip Human Genome U133Plus 2.0
arrays overnight. Hybridisation and scanning was
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performed in house at Barts Cancer Institute. For RT-
qPCR analysis, RNA in the IP material was reverse-
transcribed to cDNA using superscript III (Invitrogen)
following the manufacturer’s instructions. Quantitative
real time PCR was performed on ABI7500 equipment
using gene-specific primer pairs and amplification condi-
tion of 2 min at 50°C, 10 min at 95°C, and then 40 cycles
of 15 secs at 95°C and 45 secs at 60°C.
Total RNA was isolated using silica-based spin-
column extraction kit (RNeasy mini kit, Qiagen) follow-
ing the manufacturer’s protocol. Total RNA was treated
with RNase-free DNase1 (Ambion) to reduce genomic
DNA contamination. RNA integrity was evaluated using
the Agilent Bioanalyzer. Two micrograms of total RNA
was reverse transcribed with SuperScriptase III (Invitro-
gen) using Oligo-dT primers or random hexamers ac-
cording to the manufacturer’s protocol. Negative (−RT)
controls contained RNase-free water substituted for re-
verse transcriptase.
Recombinant BORIS purification
The mammalian expression plasmid pM49-T4738 car-
ries BORIS with an N-terminal HaloTag. Adherent
HEK293T cells were transfected using Lipofectamine
2000 (Invitrogen) using standard methods. Cells were
cultured for 48 h prior to harvest. Media were aspirated
and cells washed in cold PBS before removal by cell
scraping. Cells were centrifuged at 2000 × g for 5 min.
The cell pellet containing over-expressed HaloTag-
BORIS was stored at −80°C overnight. The cell pellet
was lysed in lysis buffer (50 mM HEPES pH7.5, 150 mM
NaCl) supplemented with BaculoGold protease inhibitor
(BD Biosciences). HaloTag-BORIS was purified as per
manufacturers protocol (Promega). The cell pellet was
lysed on ice in 1 ml of lysis buffer per 2 × 107 cells for
10 minutes, followed by 5 min pulse sonication (30 sec-
onds ON, 30 seconds OFF) using Diagenode's Bioruptor
3 min (high setting at 4°C). Crude lysate was centrifuged
at 10,000 × g for 30 min. The resulting cleared lysate
was mixed with 100 ml HaloLink resin (25% slurry), in-
cubated for 1 h rotating, and washed three times with
lysis buffer. Washes were removed through centrifuga-
tion of the HaloLink resin at 1000 ×g for 5 min and as-
piration. At the final wash, the resin was resuspended in
cleavage buffer (lysis buffer supplemented with 15 mg/ml
TEV protease) and rotated for 2 h at room temperature.
Resin was centrifuged at 2000 x g for 5 min and super-
natant removed. TEV protease was removed by the
addition of HisLink resin to the supernatant and incuba-
tion for 20 min rotating at room temperature. HisLink
was removed through centrifugation at 1000 × g for 5 min
and the resulting supernatant snap frozen in liquid nitro-
gen and stored at −80°C. Quantification of the protein was
carried out using BCA Protein Assay (Thermo Scientific).
Purification was confirmed through Western blot analysis
using rabbit anti-BORIS antibody (Abcam ab18337).
Western blot analysis
Protein extracts or precipitated protein complexes were
separated on a 4–12% gradient NuPAGE polyacrylamide
gel (Invitrogen) and then blotted onto nitrocelluose
membrane (Invitrogen) as described by Jones et al. [14].
After incubation with blocking solution (Tris-buffered
saline containing 5% skimmed milk and 0.1% Tween-20)
the membrane was incubated with corresponding anti-
bodies overnight at 4°C. After several washes, bands
were revealed with the corresponding horseradish perox-
idase coupled secondary antibody and detected using the
ECL detection kit (GE Healthcare) according to the
manufacturer’s protocol. Densitometry scanning of the
intensity of bands on the Western blot was quantified
using ImageJ. The p-values were obtained using one-way
ANNOVA test after intensity values were normalised to
GAPDH levels.
In vitro binding assay
For RNA and DNA binding assays, ~1 mg of purified
BORIS protein was incubated with 125 nM of each bio-
tinylated homopolymer in 400 ml of Binding Buffer
(RBB, 150 mM NaCl, 20 mM Tris (pH7.5), 1 mM dithio-
threitol [DTT] and 0.2% NP-40 at 4°C overnight. Nucleo-
tide:protein complexes were isolated by addition of 20 ml
prewashed Dynabeads M280 Streptavidin (Invitrogen) to
the reaction for 30 min rotating at room temperature.
Complexes were magnetically captured and washed three
times in RBB. After the final wash, beads were resus-
pended in 10 ml NuPAGE LDS sample buffer supple-
mented with 5 mM DTT, heated to 70°C for 5 min.
Captured proteins were resolved by 4 - 12% SDS/PAGE
and analysed by Western blot using anti-BORIS antibody.
Analysis of microarray data
Affymetrix Expression array files were analysed using
Partek ® software, version 6.5 Copyright © 1993–2010
(Partek Inc.). Principle component analysis (PCA) was
applied to identify any independent sources of variation
in the data. We compared data for BORIS bound RNA
transcripts with genome-wide gene expression profiles
for each selected cell type (hNP1, 6dN and HEK293T
cells) with at least two biological replicates. A t-test was
performed and transcripts were considered to be prefer-
entially associated with BORIS when the signals from
the immunoprecipitated RNA fractions were enriched
more than 2 fold, with a p-value < 0.01. The gene expres-
sion data have been deposited in NCBI’s Gene Expres-
sion Omnibus [27] and are accessible through GEO
series accession number GSE42294 (http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE42294).
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Pathway analysis and functional classification
We used Protein ANalysis THrough Evolutionary Rela-
tionships (PANTHER) software to identify significantly
enriched functional pathways and Gene Ontology (GO)
terms associated with BORIS-bound transcripts [54]. Pro-
teins were functionally classified using the PANTHER
system (http://www.PANTHERdb.org).
Quantitative real-time PCR
Both the published primers [16] and our own designed
with Primer Express 2.0 were used in this study (Table 2).
mRNA levels were quantified on an ABI7500 instrument
using SYBR Green JumpStart Taq ReadyMix kit (Sigma-
Aldrich) or platinium Taq polymerase kit (Invitrogen)
with 50–100 ng of cDNA (except for BORIS primers
when 150–200 ng of cDNA was used) and 100–200 nM
primers. We used primers spanning the exon 4/5 junc-
tion of BORIS and findings were confirmed using pub-
lished primers to exon 6/7 [15,16], and exon 9/10 [55] in
a qRT-PCR assay with various concentrations of total
cellular RNA. cDNA was generated using Oligo-dT or
random primers approach. Use of 100 ng or less RNA
resulted in inconsistent detection of BORIS. We there-
fore optimized our experiments using 150 ng total RNA
for BORIS assays and 40 ng total RNA for the highly
expressed CTCF and GAPDH assays. Absolute concen-
trations were estimated using standard curves generated
from serial dilution of amplicons. The threshold cycle
from serial dilutions of single stranded oligonucleotides
was plotted against the log copy numbers of the target
PCR products, and reported as copy numbers/μg of total
RNA [56].
Preparation and analysis of polysomes
Cell extracts for polysome analysis were prepared as de-
scribed by Camacho-Vanegas O et al. [57]. Briefly, 5 x
108 cells were incubated with cyclohexemide for 30 mi-
nutes then washed with ice-cold PBS containing 100 μg/ml
Table 2 List of primer pairs selected for RT-qPCR confirmation of BORIS associated transcripts in (A) hNP1 an hNP1
cells differentiated to neurons over 6 days (6dN), (B) HEK293T cells over-expressing BORIS
A.
Gene Forward Primer Reverse Primer Exons
RNF160 AAGTTTTGGAAGTATGGAAAACACA GCTCACTTTGGATGCTTCCTCT 6-7
TTBK2 ATTGGCTGTGGGAGGAATGA GTCTACCCAGCCGGAGAGTG 4-5
SKI CTGGACGACGTGAAGGAGAAA GGGACTGGGAAGAGGTGTCAT 1-2
PCLO CACATGCACTGAGTGTCAAACC CCGCCTAGAGCTCTTTTCATTT 3-4
APC TGGAAGCAGAGAAAGTACTGGA GATTCTGAAGTTGAGCGTAATACCA 4-5
BCL2 CCTGTGGATGACTGAGTACCTGA TCTTCAGAGACAGCCAGGAGAA 1-2
HIP1 TGTAAAGGAAAAACACGCCAGA TGTGGAACACATGGCAGAACTT 2-3
SOX4 GTTCGGCGTGTGCTTGG GCAGCGCTTCCGTGTTCT
APLP2 GCTCCTGCTTCTGCTGCTG CCCATTTCCCAGTCTGAATGTT 1-2
CALR CTCCCGATCCCAGTATCTATGC TTGTTTCTCTGCTGCCTTTGTT 7-9
POU3F1 CAACAAGTGGCTGGAGGAGAC GGCACTTGAGAAAGTGGCTCTC
B.
Gene Forward Primer Reverse Primer Exons
CHD8 CATCGAGTGTTGGATAACTTCTCTG ATCCATCATCATCAAGGGATCA 26-28
CTBP2 GAGAGTGATCGTGCGGATAGG AGAGTCCGCTGTCTCTTCCAC 5-6
CTNNB1 TGAAAATCCAGCGTGGACAAT GGTAAGACTGTTGCTGCCAGTG 2-3
FZD5 CGCTTCTCAGCGGAGTGAC AGACGGTTAGGGCTCGGATT 1-2
LEF1 AATGAGAGCGAATGTCGTTGC TCATAATATTTAGCCTGCTCTTCACG 7-8
LRP6 TTTATTGGGCAGATGCAAAACTTA AATAACGTCAAGGCAAAAGGATGT 3-4
TLE1 TCCCCCTCACATGAGAGTACC GAAAAGGGACAGGCTGCATCT 13-14
TCF4 ACCTCTTCCTGTACGCCTCCT GATCTGGAGAATAGATCGAAGCAA 11-12
TCF3 TCTCGTCCAGCCCTTCTACC CGTCCAGGTGGTCTTCTATCTTAC 13-15
WNT5A CGACATCGAAGGTGGAACTG CGTTCACCACCCCTGCT 3-4
APC TGGAAGCAGAGAAAGTACTGGA GATTCTGAAGTTGAGCGTAATACCA 4-5
TBP CACGAACCACGGCACTGATT TTTTCTTGCTGCCAGTCTGGAC 5-6
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cycloheximide (Sigma) to block ribosomes at the step of
elongation. Cells were lysed for 5 minutes in cold 1 x poly-
some buffer (10 mM Tris–HCl pH 8.0, 140 mM NaCl,
1.5 mM MgCl2 and 0.05% NP40) containing 100 μg/ml cy-
cloheximide. Cytoplasmic extracts were obtained after cen-
trifugation at 10,000 × g for 5 min at 4°C, and then loaded
onto a linear (10 – 50%) sucrose gradient in polysome buf-
fer, and centrifuged at 100,000 × g for 2 h at 4°C. 650 μl
fraction were collected and absorbance at 260 and 254 nm
was measured using a spectrophotometer (Nanodrop). Ali-
quots of each fraction was mixed with 4 x PAGE loading
buffer and analysed on a 4 – 12% NUPAGE gels.
Cloning and transfection
The GFP-BORIS, GFP-CTCF and pEGFP-C3 vectors
were transfected into HEK293T cells using FuGene 6-
HD (Roche) according to manufacturer’s protocol as
previously described [14].
Activation of relative TCF/LEF-dual luciferase assay
The effect of BORIS on the WNT pathway was evalu-
ated by measuring the activation of transcription factor
TCF/LEF with the Cignal TCF/LEF reporter assay kit
(SA Biosciences). In the first instance, HEK293T cells
were cells co-transfected with TCF/LEF reporter con-
structs and either C3-BORIS or C3-empty vector, using
Lipofectamin-2000 (Invitrogen) according to manufac-
turer's instructions. In other experiments, non-targeted
or β-catenin siRNAs (Ambion) were combined with the
C3 BORIS or C3 empty vector and co-transfected with
TCF/LEF reporter constructs (SA Biosciences) according
to manufacturer's instructions. The TCF/LEF reporter
used a mixture of an inducible β-catenin-responsive lu-
ciferase construct and a constitutively expressing Renilla
element (40:1). After 48 hrs incubation cells were
collected and analyzed for TCF/LEF activity using a
dual-luciferase assay kit (Promega-Biosciences). TCF/
LEF activation values are expressed as arbitrary units
using a Renilla reporter for internal normalization. Ex-
periments were done in duplicate, and the standard de-
viations are indicated.
Additional files
Additional file 1: Figure S1. Endogenous BORIS co-localises with newly
synthesized RNA. HEK293T cells were pulse-labelled with 5’Fuorouridine
(5’FU) for 10 minutes to label nascent RNA. Double immunoflorescence
was performed with an anti-BrdU antibody to detect 5’FU (Red) and ant-
BORIS (Green) as indicated. Nuclei were visualised with DAPI (blue).
Additional file 2: Figure S2. Partial PCR amplification of endogenous
BORIS in hNP1 cells and HEK293T cells. Gel electrophoresis analysis of
fragments used for sequencing amplified with (A) primers +67F and +633R
as previously described [22] or (B) with primers BORIS exon 9-10-11 forward:
5’-TGACCGCTCACATTCGTACC-3’ and reverse 5’-AGTGAACACGCAACCCGAAT-3’.
Additional file 3: Table S1. Probes and transcripts associated with
BORIS in hNP1 cells.
Additional file 4: Table S2. Probes and transcripts associated with
BORIS in hNP1 cells differentiated to neurons over 6 days (6dN).
Additional file 5: Table S3. BORIS-associated transcripts up- or down-
regulated during neural differentiation.
Additional file 6: Figure S4. BORIS associates with RNA transcripts in
stem cells and young neurons. BORIS associates with several transcripts
(coloured blue) of the WNT signalling pathway.
Additional file 7: Figure S5. Effects on protein levels after BORIS
overexpression in HEK293T cells. Images and the associated densitometry
measurements used to assess the protein levels of WNT5A/B and TCF3
after BORIS overexpression.
Additional file 8: Figure S3. Confirmation of BORIS antibody specificity.
Immuno-blotting of oligo-dT-RNA bound protein complexes from
HEK293T cells transiently expressing CTCF (C3-CTCF), BORIS (C3-BORIS) or
empty vector (C3-empty). Blot probed with anti BORIS antibodies.
Abbreviations
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